These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
371 related articles for article (PubMed ID: 22952452)
1. Loss of axonal mitochondria promotes tau-mediated neurodegeneration and Alzheimer's disease-related tau phosphorylation via PAR-1. Iijima-Ando K; Sekiya M; Maruko-Otake A; Ohtake Y; Suzuki E; Lu B; Iijima KM PLoS Genet; 2012; 8(8):e1002918. PubMed ID: 22952452 [TBL] [Abstract][Full Text] [Related]
2. Stabilization of Microtubule-Unbound Tau via Tau Phosphorylation at Ser262/356 by Par-1/MARK Contributes to Augmentation of AD-Related Phosphorylation and Aβ42-Induced Tau Toxicity. Ando K; Maruko-Otake A; Ohtake Y; Hayashishita M; Sekiya M; Iijima KM PLoS Genet; 2016 Mar; 12(3):e1005917. PubMed ID: 27023670 [TBL] [Abstract][Full Text] [Related]
3. Miro, a Rho GTPase genetically interacts with Alzheimer's disease-associated genes ( Panchal K; Tiwari AK Biol Open; 2020 Sep; 9(9):. PubMed ID: 32747449 [TBL] [Abstract][Full Text] [Related]
4. Ca2+/calmodulin-dependent protein kinase II promotes neurodegeneration caused by tau phosphorylated at Ser262/356 in a transgenic Drosophila model of tauopathy. Oka M; Fujisaki N; Maruko-Otake A; Ohtake Y; Shimizu S; Saito T; Hisanaga SI; Iijima KM; Ando K J Biochem; 2017 Nov; 162(5):335-342. PubMed ID: 28992057 [TBL] [Abstract][Full Text] [Related]
5. Tau Ser262 phosphorylation is critical for Abeta42-induced tau toxicity in a transgenic Drosophila model of Alzheimer's disease. Iijima K; Gatt A; Iijima-Ando K Hum Mol Genet; 2010 Aug; 19(15):2947-57. PubMed ID: 20466736 [TBL] [Abstract][Full Text] [Related]
6. Tau phosphorylation at Alzheimer's disease-related Ser356 contributes to tau stabilization when PAR-1/MARK activity is elevated. Ando K; Oka M; Ohtake Y; Hayashishita M; Shimizu S; Hisanaga S; Iijima KM Biochem Biophys Res Commun; 2016 Sep; 478(2):929-34. PubMed ID: 27520376 [TBL] [Abstract][Full Text] [Related]
7. Dissociation of tau toxicity and phosphorylation: role of GSK-3beta, MARK and Cdk5 in a Drosophila model. Chatterjee S; Sang TK; Lawless GM; Jackson GR Hum Mol Genet; 2009 Jan; 18(1):164-77. PubMed ID: 18930955 [TBL] [Abstract][Full Text] [Related]
8. Actin-microtubule crosslinker Pod-1 tunes PAR-1 signaling to control synaptic development and tau-mediated synaptic toxicity. Kang HY; Kim HJ; Kim K; Oh SI; Yoon S; Kim J; Park S; Cheon Y; Her S; Lee M; Lu B; Lee S Neurobiol Aging; 2020 Jun; 90():93-98. PubMed ID: 32169355 [TBL] [Abstract][Full Text] [Related]
9. Microtubule-affinity regulating kinase family members distinctively affect tau phosphorylation and promote its toxicity in a Drosophila model. Sultanakhmetov G; Kato I; Asada A; Saito T; Ando K Genes Cells; 2024 Apr; 29(4):337-346. PubMed ID: 38329182 [TBL] [Abstract][Full Text] [Related]
10. Microtubule affinity-regulating kinase 4 with an Alzheimer's disease-related mutation promotes tau accumulation and exacerbates neurodegeneration. Oba T; Saito T; Asada A; Shimizu S; Iijima KM; Ando K J Biol Chem; 2020 Dec; 295(50):17138-17147. PubMed ID: 33020179 [TBL] [Abstract][Full Text] [Related]
11. A DNA damage-activated checkpoint kinase phosphorylates tau and enhances tau-induced neurodegeneration. Iijima-Ando K; Zhao L; Gatt A; Shenton C; Iijima K Hum Mol Genet; 2010 May; 19(10):1930-8. PubMed ID: 20159774 [TBL] [Abstract][Full Text] [Related]
12. Neuropathogenic role of adenylate kinase-1 in Aβ-mediated tau phosphorylation via AMPK and GSK3β. Park H; Kam TI; Kim Y; Choi H; Gwon Y; Kim C; Koh JY; Jung YK Hum Mol Genet; 2012 Jun; 21(12):2725-37. PubMed ID: 22419736 [TBL] [Abstract][Full Text] [Related]
13. Cdk5 increases MARK4 activity and augments pathological tau accumulation and toxicity through tau phosphorylation at Ser262. Saito T; Oba T; Shimizu S; Asada A; Iijima KM; Ando K Hum Mol Genet; 2019 Sep; 28(18):3062-3071. PubMed ID: 31174206 [TBL] [Abstract][Full Text] [Related]
14. S6K/p70S6K1 protects against tau-mediated neurodegeneration by decreasing the level of tau phosphorylated at Ser262 in a Drosophila model of tauopathy. Chiku T; Hayashishita M; Saito T; Oka M; Shinno K; Ohtake Y; Shimizu S; Asada A; Hisanaga SI; Iijima KM; Ando K Neurobiol Aging; 2018 Nov; 71():255-264. PubMed ID: 30172839 [TBL] [Abstract][Full Text] [Related]
15. PAR-1 kinase plays an initiator role in a temporally ordered phosphorylation process that confers tau toxicity in Drosophila. Nishimura I; Yang Y; Lu B Cell; 2004 Mar; 116(5):671-82. PubMed ID: 15006350 [TBL] [Abstract][Full Text] [Related]
16. Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease. Terwel D; Dewachter I; Van Leuven F Neuromolecular Med; 2002; 2(2):151-65. PubMed ID: 12428809 [TBL] [Abstract][Full Text] [Related]
17. Activation of PAR-1 kinase and stimulation of tau phosphorylation by diverse signals require the tumor suppressor protein LKB1. Wang JW; Imai Y; Lu B J Neurosci; 2007 Jan; 27(3):574-81. PubMed ID: 17234589 [TBL] [Abstract][Full Text] [Related]
18. Abeta exacerbates the neuronal dysfunction caused by human tau expression in a Drosophila model of Alzheimer's disease. Folwell J; Cowan CM; Ubhi KK; Shiabh H; Newman TA; Shepherd D; Mudher A Exp Neurol; 2010 Jun; 223(2):401-9. PubMed ID: 19782075 [TBL] [Abstract][Full Text] [Related]
19. Loss of Tau results in defects in photoreceptor development and progressive neuronal degeneration in Drosophila. Bolkan BJ; Kretzschmar D Dev Neurobiol; 2014 Dec; 74(12):1210-25. PubMed ID: 24909306 [TBL] [Abstract][Full Text] [Related]
20. Tau accumulation in the retina promotes early neuronal dysfunction and precedes brain pathology in a mouse model of Alzheimer's disease. Chiasseu M; Alarcon-Martinez L; Belforte N; Quintero H; Dotigny F; Destroismaisons L; Vande Velde C; Panayi F; Louis C; Di Polo A Mol Neurodegener; 2017 Aug; 12(1):58. PubMed ID: 28774322 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]